ClinicalTrials.gg
CompletedNCT07010601Updated Oct 15, 2026Results posted

Tobacco Product Susceptibility and Substitutability by Rurality and Alcohol Use

An interventional study of Experimental Tobacco Marketplace and Hypothetical Novel Nicotine Product Purchase Tasks in Alcohol Use, E-cigarette Use and Cigarette Use, sponsored by Mark J Rzeszutek, PhD. Completed at 1 site in United States. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-15.

Primary conditionVapingRegistry: Alcohol DrinkingReclassifiedWhy we changed it
Registry
Alcohol Drinking — the first condition term the registry derived for this study.
ClinicalTrials.gg
Vaping
Why
  1. Alcohol Drinking is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Vaping.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Mark J Rzeszutek, PhD · Not applicable, Interventional, and Other

How we know

Updated Oct 15, 2026Results postedStudy documents posted+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
737
Allocation
Non-randomized
Ages
21 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 288 studies in Vaping with a site in United States — 66 open to participants now, 74 under way, 1 of them phase 3. Vaping · United States.

Enrollment
29th of 258
737 · median 71
Started
2025
with 36 others
No phase
206 of 288
39 open now
Registered
247th of 288
by date

Among the 288 studies in Vaping with a site in United States, this one is the 29th largest by enrollment of the 258 interventional ones that give a count, is one of 37 that started in 2025, is one of 206 with no phase, and was the 247th registered.

Vaping

404 studies on the registry are indexed under Vaping; 97 are open to participants now.

Browse Vaping studies →

Open to participants now

66 of the 288 studies in Vaping with a site in United States are open now. Recruiting first, the newest first:

61 more — sign in →

All 66 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 65 Vaping studies recruiting now, 33 (51%) set no upper age limit and 31 (48%) stop at 75 or younger; 13 take children under 18; 40 take healthy volunteers.

This study: 21 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 288 studies in Vaping with a site in United States, or all of them as a file.
02

Study summary

A high priority research area for the Food and Drug Administration Center for Tobacco Products (FDA CTP) is determining who will start using tobacco products and who will stop using tobacco products. A population that has a disproportionately high amount of tobacco use are people living in rural areas. This indicates that some aspect of rurality is related to tobacco product susceptibility and decreased tobacco cessation rates. People in rural areas also typically have higher rates of alcohol use, which is also associated with higher tobacco use and decreased tobacco cessation rates. The purpose of this study is to (1) examine how rurality and alcohol use may affect susceptibility to existing and novel tobacco products and (2) examine how rurality and alcohol use may affect likelihood for tobacco users to substitute to tobacco cessation products. To accomplish this, the investigators will use behavioral economic measures to assess how people respond to novel tobacco products (high and low nicotine, flavored and unflavored), as well as use the experimental tobacco marketplace to determine how current users might switch to products associated with cessation. Because rurality is a spectrum, the investigators will be using an index of relative rurality (IRR) to better quantify how rurality and alcohol use affect these tobacco-related behaviors.

03

Conditions studied

  • Alcohol Use
  • E-cigarette Use
  • Cigarette Use

Browse trials for

04

In context

Vaping Reclassified

404 studies on the registry are indexed under Vaping; 97 are open to participants now.

This study's enrollment of 737 is above the median of 79 across 324 interventional studies indexed under Vaping.

Browse Vaping studies →

Lead sponsor

Mark J Rzeszutek, PhD is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Compared within Vaping, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Alcohol Drinking. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Cigarette/E-Cigarette Users

Inclusion Criteria:

  • 21 years of age or older
  • Smoke cigarettes or use e-cigarettes 25 or more days a month

Cigarette/E-Cigarette Non-Users

Inclusion Criteria:

  • 21 years of age or older
  • Do not report using an e-cigarette or cigarette in the past month

Risky Alcohol Users

Inclusion Criteria:

  • 21 years of age or older
  • A score of 8 or higher on the Alcohol Use Disorder Identification Test

Non-Risky Alcohol Users

Inclusion Criteria:

  • 21 years of age or older
  • A score of 7 or lower on the Alcohol Use Disorder Identification Test

All groups

Inclusion Criteria:

  • Located in the USA
  • At least 100 complete studies on Prolific

Exclusion Critera:

  • Failing attention checks during the screener
06

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
737 participants (actual)

Study arms

  • Experimental
    Low Alcohol Use + No Cigarette/E-Cigarette Use

    Participants with low alcohol use and no cigarette or e-cigarette use will complete a Qualtrics survey consisting of various decision-making tasks, and novel hypothetical nicotine product demand tasks

    Behavioral: Hypothetical Novel Nicotine Product Purchase Tasks

  • Experimental
    High Alcohol Use + No Cigarette/E-Cigarette Use

    Participants with high alcohol use and no cigarette or e-cigarette use will complete a Qualtrics survey consisting of various decision-making tasks, and novel hypothetical nicotine product demand tasks.

    Behavioral: Hypothetical Novel Nicotine Product Purchase Tasks

  • Experimental
    Low Alcohol Use + Cigarette/E-Cigarette Use

    Participants with low alcohol use and cigarette or e-cigarette use will complete a Qualtrics survey consisting of various decision-making tasks, novel hypothetical nicotine product demand tasks, and Experimental Tobacco Marketplace scenarios (ETM). There will be three total ETM scenarios, cigarette adjusting price, e-cigarette adjusting price, and both e-cigarette and cigarette adjusting price.

    Behavioral: Experimental Tobacco Marketplace · Behavioral: Hypothetical Novel Nicotine Product Purchase Tasks

  • Experimental
    High Alcohol Use + Cigarette/E-Cigarette Use

    Participants with high alcohol use and cigarette or e-cigarette usewill complete a Qualtrics survey consisting of various decision-making tasks, novel hypothetical nicotine product demand tasks, and Experimental Tobacco Marketplace scenarios (ETM). There will be three total ETM scenarios, cigarette adjusting price, e-cigarette adjusting price, and both e-cigarette and cigarette adjusting price.

    Behavioral: Experimental Tobacco Marketplace · Behavioral: Hypothetical Novel Nicotine Product Purchase Tasks

Interventions

  • BehavioralExperimental Tobacco Marketplace

    This study will have three different scenarios in the Experimental Tobacco Marketplace (ETM) for participants who reported being cigarette and/or e-cigarette users. These will consist of hypothetical purchase scenarios where a variety of different tobacco products are available to purchase. The three ETM scenarios will be adjusting price cigarettes, adjusting price e-cigarettes, and both adjusting price cigarettes and e-cigarettes.

  • BehavioralHypothetical Novel Nicotine Product Purchase Tasks

    This study will have a set of hypothetical demand tasks for novel nicotine products. These tasks consist of different novel hypothetical products (combusted, oral, and vaporized) of differing nicotine content (high and low), and different flavors (preferred alcoholic flavor, no characterizing flavor) where likelihood to try is assessed at a variety of price points.

07

What researchers measure

Primary outcomes

  1. Demand Intensity for Hypothetical Nicotine Products

    Demand intensity was assessed using hypothetical purchase tasks in which participants reported the number of products they would purchase at varying prices. In this case, demand intensity refers to the likelihood to try/consume a novel nicotine product when then cost of that product was free (i.e., likelihood to try at $0 ranging from 0-100).

    Time frame: Baseline (study week 0) During the Hypothetical Purchase Task

  2. Price Sensitivity for Hypothetical Nicotine Products

    Demand sensitivity to novel hypothetical products was assessed for flavor, nicotine, and product type. Sensitivity was measured by finding the highest likelihood times cost per participant per condition, or the maximum likelihood expenditure (also referred to as Omax). Based on the task used, values can range from 0-5000.

    Time frame: Baseline (study week 0) During the Hypothetical Purchase Task

  3. Alternative Product Purchasing as a Function of Change in Price of Cigarettes and/or E-Cigarettes in the Experimental Tobacco Marketplace

    Cigarette and e-cigarette users completed three different experimental tobacco marketplaces. They each completed a marketplace where e-cigarettes adjusted in price, another where cigarettes adjusted in price, and a third where both cigarettes and e-cigarettes adjusted in price. Then substitution for different product categories was assessed by the difference in amount spent in USD at the lowest price of the adjusting product to the highest price of the adjusting product. Positive values indicate an increase in consumption as a function of increasing cost of the adjusting price product (i.e., substitution).

    Time frame: Baseline (study week 0) During the Hypothetical Purchase Task

08

Results

Posted Oct 15, 2026

Participant flow

Participant flow — Overall Study
MilestoneLow Alcohol Use + No Cigarette/E-Cigarette UseHigh Alcohol Use + No Cigarette/E-Cigarette UseLow Alcohol Use + Cigarette/E-Cigarette UseHigh Alcohol Use + Cigarette/E-Cigarette Use
Started200161157219
Completed200161157219
Not completed0000

Outcome measures

PrimaryDemand Intensity for Hypothetical Nicotine Products

Demand intensity was assessed using hypothetical purchase tasks in which participants reported the number of products they would purchase at varying prices. In this case, demand intensity refers to the likelihood to try/consume a novel nicotine product when then cost of that product was free (i.e., likelihood to try at $0 ranging from 0-100).

Time frame:
Baseline (study week 0) During the Hypothetical Purchase Task
Reported as:
Mean · Number of Products Purchased
Demand Intensity for Hypothetical Nicotine Products
Number of Products PurchasedLow Alcohol Use + No Cigarette/E-Cigarette UseHigh Alcohol Use + No Cigarette/E-Cigarette UseLow Alcohol Use + Cigarette/E-Cigarette UseHigh Alcohol Use + Cigarette/E-Cigarette Use
Oral Product Unflavored Low Nicotine Mean Intensity16.66 ± 31.9319.24 ± 31.8750.42 ± 44.8661.9 ± 44.01
Oral Product Unflavored High Nicotine Mean Intensity13.43 ± 28.2417.01 ± 30.4555.05 ± 45.0765.51 ± 41.28
Oral Product Flavored Low Nicotine Mean Intensity21.46 ± 34.6823.79 ± 35.6352.3 ± 45.7960.8 ± 43.68
Oral Product Flavored High Nicotine Mean Intensity17.96 ± 32.622.9 ± 35.1653.91 ± 45.1565.58 ± 41.52
Vaporized Product Unflavored Low Nicotine Mean Intensity18.6 ± 33.0315.97 ± 30.5766.21 ± 4174.08 ± 37.73
Vaporized Product Unflavored High Nicotine Mean Intensity14.73 ± 29.3715.24 ± 29.5267.68 ± 41.4479.11 ± 33.73
Vaporized Product Flavored Low Nicotine Mean Intensity23.53 ± 35.5324.43 ± 36.3368.19 ± 41.873.09 ± 39.05
Vaporized Product Flavored High Nicotine Mean Intensity19.42 ± 30.421.01 ± 27.4367.14 ± 44.6276.38 ± 39.45
Combusted Product Unflavored Low Nicotine Mean Intensity16.38 ± 33.7813.87 ± 33.4351.68 ± 41.8669.5 ± 36.6
Combusted Product Unflavored High Nicotine Mean Intensity14.63 ± 29.1615.95 ± 30.5356.41 ± 44.5375.58 ± 35.06
Combusted Product Flavored Low Nicotine Mean Intensity22.2 ± 35.220.67 ± 34.7255.36 ± 44.8765.65 ± 40.98
Combusted Product Flavored High Nicotine Mean Intensity18.84 ± 33.4720.31 ± 33.854.96 ± 44.2471.79 ± 38.62
PrimaryPrice Sensitivity for Hypothetical Nicotine Products

Demand sensitivity to novel hypothetical products was assessed for flavor, nicotine, and product type. Sensitivity was measured by finding the highest likelihood times cost per participant per condition, or the maximum likelihood expenditure (also referred to as Omax). Based on the task used, values can range from 0-5000.

Time frame:
Baseline (study week 0) During the Hypothetical Purchase Task
Reported as:
Mean · Number of Products Bought per U.S.Dollar
Price Sensitivity for Hypothetical Nicotine Products
Number of Products Bought per U.S.DollarLow Alcohol Use + No Cigarette/E-Cigarette UseHigh Alcohol Use + No Cigarette/E-Cigarette UseLow Alcohol Use + Cigarette/E-Cigarette UseHigh Alcohol Use + Cigarette/E-Cigarette Use
Oral Product Unflavored Low Nicotine Mean Intensity92.48 ± 397.07122.24 ± 550.11160.79 ± 306.81350.5 ± 826.99
Oral Product Unflavored High Nicotine Mean Intensity84.05 ± 347.72121.42 ± 579.77222.22 ± 505.57390.29 ± 787.1
Oral Product Flavored Low Nicotine Mean Intensity134.8 ± 432.8134.08 ± 586.39270.56 ± 647.17408.97 ± 890.18
Oral Product Flavored High Nicotine Mean Intensity126.65 ± 474.2127.13 ± 563.35255.25 ± 459.25451.51 ± 877.31
Vaporized Product Unflavored Low Nicotine Mean Intensity90.22 ± 357.9139.17 ± 658.91295.73 ± 516.33465.92 ± 799.81
Vaporized Product Unflavored High Nicotine Mean Intensity98.92 ± 491.33136.93 ± 635.64364.84 ± 668.99596.02 ± 903.68
Vaporized Product Flavored Low Nicotine Mean Intensity168.25 ± 569.19161.78 ± 708.2432.2 ± 694.47526.71 ± 929.17
Vaporized Product Flavored High Nicotine Mean Intensity113.22 ± 421.38153.86 ± 645.09472.01 ± 753.63677.82 ± 999.08
Combusted Product Unflavored Low Nicotine Mean Intensity112.32 ± 447.39104.5 ± 490.11186.58 ± 403.25365.93 ± 715.6
Combusted Product Unflavored High Nicotine Mean Intensity85.98 ± 349.21108.11 ± 474.93242.78 ± 450.25458.02 ± 800.12
Combusted Product Flavored Low Nicotine Mean Intensity163.67 ± 593.53163.85 ± 629.11267.18 ± 480.95444.24 ± 857.65
Combusted Product Flavored High Nicotine Mean Intensity143.3 ± 488.66138 ± 524.51321.26 ± 554.91527.08 ± 899.86
PrimaryAlternative Product Purchasing as a Function of Change in Price of Cigarettes and/or E-Cigarettes in the Experimental Tobacco Marketplace

Cigarette and e-cigarette users completed three different experimental tobacco marketplaces. They each completed a marketplace where e-cigarettes adjusted in price, another where cigarettes adjusted in price, and a third where both cigarettes and e-cigarettes adjusted in price. Then substitution for different product categories was assessed by the difference in amount spent in USD at the lowest price of the adjusting product to the highest price of the adjusting product. Positive values indicate an increase in consumption as a function of increasing cost of the adjusting price product (i.e., substitution).

Time frame:
Baseline (study week 0) During the Hypothetical Purchase Task
Reported as:
Mean · Number of Products Bought per U.S.Dollar
Alternative Product Purchasing as a Function of Change in Price of Cigarettes and/or E-Cigarettes in the Experimental Tobacco Marketplace
Number of Products Bought per U.S.DollarLow Alcohol Use + No Cigarette/E-Cigarette UseHigh Alcohol Use + No Cigarette/E-Cigarette UseLow Alcohol Use + Cigarette/E-Cigarette UseHigh Alcohol Use + Cigarette/E-Cigarette Use
E-Cigarette Marketplace Combusted Product Substitution——0.69 ± 4.090.48 ± 2.87
E-Cigarette Marketplace Non-Combusted Product Substitution——0.26 ± 0.880.19 ± 0.79
E-Cigarette Marketplace Quit Product Substitution——0.08 ± 0.50.02 ± 0.47
E-Cigarette Marketplace Cigarettes Product Substitution——0.03 ± 1.460.13 ± 1.49
Cigarette Marketplace Combusted Product Substitution——1.87 ± 6.91.39 ± 4.65
Cigarette Marketplace Non-Combusted Product Substitution——0.14 ± 1.040.21 ± 1.27
Cigarette Marketplace Quit Product Substitution——0.06 ± 0.410 ± 0.21
Cigarette Marketplace E-Cigarettes Product Substitution——0.01 ± 1.340.35 ± 1.73
Combined Marketplace Combusted Product Substitution——2.01 ± 4.962.29 ± 5.72
Combined Marketplace Non-Combusted Product Substitution——0.45 ± 1.150.31 ± 1.39
Combined Marketplace Quit Product Substitution——0.14 ± 0.540.13 ± 0.52

Adverse events

Collected over 60 Minutes. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Low Alcohol Use + No Cigarette/E-Cigarette Use0/200 (0%)0/200 (0%)0/200 (0%)
High Alcohol Use + No Cigarette/E-Cigarette Use0/161 (0%)0/161 (0%)0/161 (0%)
Low Alcohol Use + Cigarette/E-Cigarette Use0/157 (0%)0/157 (0%)0/157 (0%)
High Alcohol Use + Cigarette/E-Cigarette Use0/219 (0%)0/219 (0%)0/219 (0%)

Baseline characteristics

The number of participants reported in each arm described here is prior to any data quality checks based on participants responding to embedded attention checks in the surveys or if participants responded in an inconsistent manner for the types of tobacco products they reported using.

Age, Continuous
Age, Continuous(years)Low Alcohol Use + No Cigarette/E-Cigarette UseHigh Alcohol Use + No Cigarette/E-Cigarette UseLow Alcohol Use + Cigarette/E-Cigarette UseHigh Alcohol Use + Cigarette/E-Cigarette UseTotal
Mean46.46 ± 13.0444 ± 12.0543.41 ± 12.1339.95 ± 10.8843.4 ± 12.27
Sex: Female, Male
Sex: Female, Male(Participants)Low Alcohol Use + No Cigarette/E-Cigarette UseHigh Alcohol Use + No Cigarette/E-Cigarette UseLow Alcohol Use + Cigarette/E-Cigarette UseHigh Alcohol Use + Cigarette/E-Cigarette UseTotal
Female96568580317
Male969466129385
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Low Alcohol Use + No Cigarette/E-Cigarette UseHigh Alcohol Use + No Cigarette/E-Cigarette UseLow Alcohol Use + Cigarette/E-Cigarette UseHigh Alcohol Use + Cigarette/E-Cigarette UseTotal
American Indian or Alaska Native00213
Asian1053725
Native Hawaiian or Other Pacific Islander30003
Black or African American1515202474
White152121113158544
More than one race129131953
Unknown or Not Reported00011
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Low Alcohol Use + No Cigarette/E-Cigarette UseHigh Alcohol Use + No Cigarette/E-Cigarette UseLow Alcohol Use + Cigarette/E-Cigarette UseHigh Alcohol Use + Cigarette/E-Cigarette UseTotal
Hispanic or Latino961622
Not Hispanic or Latino183144150204681
Unknown or Not Reported00000
Region of Enrollment
Region of Enrollment(participants)Low Alcohol Use + No Cigarette/E-Cigarette UseHigh Alcohol Use + No Cigarette/E-Cigarette UseLow Alcohol Use + Cigarette/E-Cigarette UseHigh Alcohol Use + Cigarette/E-Cigarette UseTotal
United States200161157219737
09

Study locations

1 site
  • University of Kentucky
    Lexington, Kentucky 40506, United States
10

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — Deidentified data from this study will be made as available as possible after acceptance for publication. All shared data will comply with HIPAA guidelines on personally identifiable information. Code used for analyses will also accompany deidentified data.

Supporting information: Analytic code

11

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2025 to primary completion in Aug 2025, 0 months.

Results were first posted in Oct 2026, 1 year 1 month after primary completion.

Of 184 non-industry interventional studies with no phase under Vaping, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's 0 months is below that.

Counting every sponsor, half of 208 studies reached it within 18 months; a quarter within 6 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
May 21, 2025
First posted
Jun 8, 2025
StartActual
Aug 18, 2025
Primary completionActual
Aug 20, 2025
CompletionActual
Aug 20, 2025
Results first posted
Oct 15, 2026
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Oct 15, 2026
Interventions
Arms added: Low Alcohol Use + No Cigarette/E-Cigarette Use·High Alcohol Use + No Cigarette/E-Cigarette Use·Low Alcohol Use + Cigarette/E-Cigarette Use·High Alcohol Use + Cigarette/E-Cigarette Use; arms removed: Qualtrics and Experimental Tobacco Marketplace·Qualtrics Only
Oct 15, 2026
Primary outcomes
1 edited, 1 time frame changed, 1 added, 1 description edited
What changed in the outcomes
  • EditedDemand Intensity and Price Sensitivity for Hypothetical Nicotine ProductsTime frame: Assessed at study week 0 → Baseline (study week 0) During the Hypothetical Purchase Task
  • AddedPrice Sensitivity for Hypothetical Nicotine ProductsTime frame: Baseline (study week 0) During the Hypothetical Purchase Task
  • Time frameAlternative Product Purchasing as a Function of Change in Price of Cigarettes and/or E-Cigarettes in the Experimental Tobacco MarketplaceAssessed at study week 0 → Baseline (study week 0) During the Hypothetical Purchase Task
  • DescriptionAlternative Product Purchasing as a Function of Change in Price of Cigarettes and/or E-Cigarettes in the Experimental Tobacco Marketplace: how it is measured was reworded
Oct 15, 2026
Documents
Show all 1 update
  1. Oct 15, 2026
    Results posted
    Primary outcomes 1 edited, 1 time frame changed, 1 added, 1 description edited
    What changed in the outcomes
    • EditedDemand Intensity and Price Sensitivity for Hypothetical Nicotine ProductsTime frame: Assessed at study week 0 → Baseline (study week 0) During the Hypothetical Purchase Task
    • AddedPrice Sensitivity for Hypothetical Nicotine ProductsTime frame: Baseline (study week 0) During the Hypothetical Purchase Task
    • Time frameAlternative Product Purchasing as a Function of Change in Price of Cigarettes and/or E-Cigarettes in the Experimental Tobacco MarketplaceAssessed at study week 0 → Baseline (study week 0) During the Hypothetical Purchase Task
    • DescriptionAlternative Product Purchasing as a Function of Change in Price of Cigarettes and/or E-Cigarettes in the Experimental Tobacco Marketplace: how it is measured was reworded
    Interventions Arms added: Low Alcohol Use + No Cigarette/E-Cigarette Use·High Alcohol Use + No Cigarette/E-Cigarette Use·Low Alcohol Use + Cigarette/E-Cigarette Use·High Alcohol Use + Cigarette/E-Cigarette Use; arms removed: Qualtrics and Experimental Tobacco Marketplace·Qualtrics Only
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

12

Registry details

Key details

Study ID
NCT07010601
Lead sponsor
Mark J Rzeszutek, PhD
Responsible party
Mark J Rzeszutek, PhD (Principal Investigator, University of Kentucky) — Sponsor-investigator
First posted
Jun 8, 2025
Start date
Aug 18, 2025
Primary completion
Aug 20, 2025
Completion
Aug 20, 2025
Results posted
Oct 15, 2026
Last update
Oct 15, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion